Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $7.5B and total debt of $597.3M, which brings its debt-to-equity ratio to 8%. Its total assets and total liabilities are $10.1B and $2.6B respectively. Edwards Lifesciences's EBIT is $1.9B making its interest coverage ratio -31.5. It has cash and short-term investments of $2.0B.
Key information
8.0%
Debt to equity ratio
US$597.30m
Debt
| Interest coverage ratio | -31.5x |
| Cash | US$1.99b |
| Equity | US$7.50b |
| Total liabilities | US$2.59b |
| Total assets | US$10.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: E1WL34's short term assets ($4.5B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: E1WL34's short term assets ($4.5B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: E1WL34 has more cash than its total debt.
Reducing Debt: E1WL34's debt to equity ratio has reduced from 17% to 8% over the past 5 years.
Debt Coverage: E1WL34's debt is well covered by operating cash flow (145%).
Interest Coverage: E1WL34 earns more interest than it pays, so coverage of interest payments is not a concern.